Brainsway Stock Today
| BWAY Stock | USD 9.87 0.19 1.96% |
Performance11 of 100
| Odds Of DistressLess than 41
|
Brainsway is trading at 9.87 as of the 30th of November 2024; that is 1.96 percent increase since the beginning of the trading day. The stock's open price was 9.68. Brainsway has about a 41 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Brainsway are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 6th of October 1999 | Category Healthcare | Classification Health Care |
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 18.78 M outstanding shares of which 30.6 K shares are currently shorted by private and institutional investors with about 0.33 trading days to cover. More on Brainsway
Moving together with Brainsway Stock
Moving against Brainsway Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Brainsway Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBrainsway can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Brainsway's financial leverage. It provides some insight into what part of Brainsway's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brainsway (BWAY) is traded on NASDAQ Exchange in USA. It is located in Bynet Building, Jerusalem, Israel, 9777518 and employs 134 people. Brainsway is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 185.39 M. Brainsway conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 18.78 M outstanding shares of which 30.6 K shares are currently shorted by private and institutional investors with about 0.33 trading days to cover.
Brainsway currently holds about 49.62 M in cash with 1.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.95.
Check Brainsway Probability Of Bankruptcy
Ownership AllocationBrainsway holds a total of 18.78 Million outstanding shares. Almost 80.78 percent of Brainsway outstanding shares are held by general public with 19.22 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Brainsway Ownership Details
Brainsway Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Good Life Advisors, Llc | 2024-09-30 | 55.8 K | |
| Citadel Advisors Llc | 2024-09-30 | 53.2 K | |
| Perritt Capital Management Inc. | 2024-09-30 | 20 K | |
| Two Sigma Advisers, Llc | 2024-06-30 | 19.2 K | |
| Millennium Management Llc | 2024-06-30 | 18.3 K | |
| Rhumbline Advisers | 2024-06-30 | 18.1 K | |
| Cubist Systematic Strategies, Llc | 2024-09-30 | 16.8 K | |
| Zuckerman Investment Group, Llc | 2024-09-30 | 15 K | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 13.8 K | |
| Masters Capital Management Llc | 2024-09-30 | 900 K | |
| Renaissance Technologies Corp | 2024-09-30 | 361.2 K |
Brainsway Historical Income Statement
Brainsway Stock Against Markets
Brainsway Corporate Management
| Christopher Jako | Pres CEO | Profile | |
| Ido Marom | Chief Officer | Profile | |
| Gilead Moiseyev | Chief Officer | Profile | |
| Moria Ankri | VP RD | Profile | |
| Pr Zangen | Member CoFounder | Profile | |
| Hillegonda Groen | Vice Sales | Profile | |
| Ross Mitchell | Vice Marketing | Profile |
Additional Tools for Brainsway Stock Analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.